Answers are grounded in this paper and cite their sources.
Despite conserved mechanisms maintaining energy homeostasis, the global obesity epidemic continues to rise. Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is an anti-inflammatory regulator essential for immune homeostasis, yet its role in adipogenesis remains unclear. Here, we show that TIPE2 expression in human adipose tissue is inversely correlated with body mass index (BMI) and metabolic dysfunction. In mice, Tipe2 deficiency exacerbates diet-induced obesity, hyperglycaemia, and insulin resistance, whereas systemic AAV-mediated TIPE2 overexpression alleviates these phenotypes. In vitro, TIPE2 suppresses adipogenic differentiation in primary preadipocytes. Mechanistically, TIPE2 regulates N6-methyladenosine (m6A) via m6A methyltransferase-like 14 (METTL14). Loss of TIPE2 reduces m6A levels and METTL14 expression, whereas METTL14 restoration reverses the pro-adipogenic effects. Furthermore, TIPE2 modulates adipogenesis through peroxisome proliferator-activated receptor-γ (PPAR-γ) signaling. Together, these findings identify TIPE2 as a suppressor of adipogenesis via coordinated regulation of METTL14-dependent m6A modification and PPAR-γ signaling.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: